Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Phenserine – Next Generation AChE Inhibitor

Drug (Brand / Generic)

Phenserine

Company / Licensee

Axonyx

Therapy Class

AChE inhibitor

Product Description

Dual-acting AChE inhibitor and anti-amyloid agent

Current Indication

Alzheimer's disease

Market Sector

CNS

Development Status

Phase III failed, now testing follow-on compounds
Expand

Go Top